POLR2K expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.08266778559619E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.20095078115901E-12 |
Normal-vs-Stage2 |
4.085000E-03 |
Normal-vs-Stage3 |
8.74409999962467E-09 |
Normal-vs-Stage4 |
8.21720025356854E-10 |
Stage1-vs-Stage2 |
1.551820E-01 |
Stage1-vs-Stage3 |
6.647400E-01 |
Stage1-vs-Stage4 |
9.348200E-01 |
Stage2-vs-Stage3 |
9.916000E-02 |
Stage2-vs-Stage4 |
1.595560E-01 |
Stage3-vs-Stage4 |
7.411800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.07529598745305E-11 |
Normal-vs-AfricanAmerican |
1.0156999685762E-09 |
Normal-vs-Asian |
2.536300E-03 |
Caucasian-vs-AfricanAmerican |
7.779400E-01 |
Caucasian-vs-Asian |
5.937000E-01 |
AfricanAmerican-vs-Asian |
4.418000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62180002760692E-09 |
Normal-vs-Female |
8.94450069566233E-11 |
Male-vs-Female |
7.973800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.94399990233785E-10 |
Normal-vs-Age(41-60Yrs) |
2.40107933535683E-12 |
Normal-vs-Age(61-80Yrs) |
1.09059999919836E-08 |
Normal-vs-Age(81-100Yrs) |
8.424000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.644400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.873000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.675170E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.326800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.954410E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.133400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.863600E-03 |
Normal-vs-Grade 2 |
8.45030000418134E-08 |
Normal-vs-Grade 3 |
4.77173855983892E-13 |
Normal-vs-Grade 4 |
4.62290206115767E-11 |
Grade 1-vs-Grade 2 |
9.838200E-01 |
Grade 1-vs-Grade 3 |
2.512400E-01 |
Grade 1-vs-Grade 4 |
3.550400E-01 |
Grade 2-vs-Grade 3 |
1.454170E-02 |
Grade 2-vs-Grade 4 |
7.620400E-02 |
Grade 3-vs-Grade 4 |
8.648400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.87140303253841E-11 |
Normal-vs-ccB subtype |
3.15480000012691E-07 |
ccA subtype-vs-ccB subtype |
4.619600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.6208000455178E-09 |
Normal-vs-N1 |
1.66776999999119E-05 |
N0-vs-N1 |
4.658000E-01 |
|
|